H-CYTE: H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc. Targets one of Healthcare's Largest Multi-Billion Dollar Markets: Cardiac Electrophysiology
H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter Precision, Inc.
Read full article »
CEO
Michael Yurkowsky
H-CYTE is a biotech company that develops and commercializes therapies for the treatment for lung diseases.
Read more